Systems modeling helps optimize safety and efficacy for oncolytic viruses
2025年5月30日 Gene therapies delivered in viral vectors offer an exciting and challenging approach…
Certara2025年5月30日
‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented
Editor’s Note: Jiwon Oh provided research support for this article. She is a Certara Market…
Certara2025年5月23日
CERTAINTY 2025: The power of Model-Informed Drug Development
We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…
Certara2025年5月16日
Extrapolating AUC to Infinity
AUC calculations are simple but nuanced. In this blog, we look at how to extrapolate…
Certara2025年5月15日
QSP Summit 2025: A New Standard in the Future of Drug Development
2025年5月5日 The Quantitative Systems Pharmacology (QSP) Summit 2025, hosted by Certara, marked another…
Certara2025年5月5日
Essentials of Model-informed Drug Development in Oncology
Model-informed drug development in oncology is critical to developing safer and more effective cancer drugs.…
Certara2025年5月2日
SEND V4.0 – What to Expect and When to Expect It
2025年4月24日 As the Standard for Exchange of Nonclinical Data (SEND) continues to evolve…
Certara2025年4月24日
Best Practices for AI Prompt Engineering in Life Sciences
2025年4月23日 Prompt engineering is an emerging skill introduced to the public with the…
Certara2025年4月23日
Managing Clinical Metadata for your Vendors, Studies, and Datasets
2025年4月21日 Clinical research is witnessing an evolution, driven by the increasing complexities of…
Certara2025年4月21日
In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)
2025年4月18日 What’s next for drug development? Recapping our MIDD in the age of…
Certara2025年4月18日
